Blueprint Medicines Soars 26% on $9.5 Billion Buyout. Why This Drug Is Key to the Deal.
Latest News
- How much money should you keep in a high-yield savings account?
- Crypto Innovation in Canada Stifled by the 'Idiot King' Trudeau: Kevin O'Leary
- 10 best high-yield money market accounts for June 2025: Rates up to 4.4% APY
- Apple Stock Has ‘Significant,’ Long-Term Opportunities. The Case for Buying Now.
- First Solar Stock Falls. Wall Street Is Split on Fate of Renewables.
- Favorite Casino Stock Traders Should Avoid in June